Universe Pharmaceuticals INC
UPC
$2.91
-$0.71-19.61%
NASDAQ
| 09/30/2025 | 06/30/2025 | 09/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -193.70K | -193.70K | -3.17M | -6.55M | -6.55M |
| Total Depreciation and Amortization | 123.90K | 123.90K | 118.40K | 124.40K | 124.40K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 185.30K | 185.30K | 213.80K | 5.54M | 5.54M |
| Change in Net Operating Assets | -3.92M | -3.92M | -701.60K | -327.00K | -327.00K |
| Cash from Operations | -3.81M | -3.81M | -3.54M | -1.21M | -1.21M |
| Capital Expenditure | -85.00K | -85.00K | -89.10K | -33.80K | -33.80K |
| Sale of Property, Plant, and Equipment | 2.70K | 2.70K | 900.00 | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -22.20K | -22.20K | -58.60K | 0.00 | 0.00 |
| Cash from Investing | -104.50K | -104.50K | -146.80K | -33.80K | -33.80K |
| Total Debt Issued | 4.09M | 4.09M | 5.07M | 3.59M | 3.59M |
| Total Debt Repaid | -7.43M | -7.43M | -3.63M | -555.10K | -555.10K |
| Issuance of Common Stock | 0.00 | 0.00 | 12.50M | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -3.34M | -3.34M | 13.94M | 3.03M | 3.03M |
| Foreign Exchange rate Adjustments | 407.00K | 407.00K | 59.70K | 2.90K | 2.90K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -6.84M | -6.84M | 10.32M | 1.79M | 1.79M |